Livforsakringsbolaget Skandia Omsesidigt Purchases 3,331 Shares of Agilent Technologies, Inc. (NYSE:A)

Livforsakringsbolaget Skandia Omsesidigt increased its position in Agilent Technologies, Inc. (NYSE:A) by 82.9% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,351 shares of the medical research company’s stock after buying an additional 3,331 shares during the quarter. Livforsakringsbolaget Skandia Omsesidigt’s holdings in Agilent Technologies were worth $1,091,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also bought and sold shares of A. Crewe Advisors LLC grew its stake in shares of Agilent Technologies by 114.8% during the second quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock valued at $25,000 after buying an additional 101 shares during the last quarter. Livelsberger Financial Advisory bought a new position in Agilent Technologies during the 4th quarter worth approximately $26,000. Ridgewood Investments LLC purchased a new position in Agilent Technologies in the 2nd quarter worth approximately $29,000. Rise Advisors LLC lifted its position in Agilent Technologies by 527.8% in the first quarter. Rise Advisors LLC now owns 226 shares of the medical research company’s stock valued at $33,000 after purchasing an additional 190 shares during the last quarter. Finally, Ashton Thomas Private Wealth LLC purchased a new stake in shares of Agilent Technologies during the second quarter valued at approximately $39,000.

Insider Buying and Selling at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 1,958 shares of the company’s stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total value of $283,910.00. Following the transaction, the chief executive officer now owns 24,118 shares in the company, valued at $3,497,110. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In related news, SVP Dominique Grau sold 9,990 shares of the business’s stock in a transaction that occurred on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total value of $1,448,550.00. Following the completion of the transaction, the senior vice president now directly owns 40,011 shares in the company, valued at $5,801,595. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Padraig Mcdonnell sold 1,958 shares of the company’s stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total value of $283,910.00. Following the completion of the transaction, the chief executive officer now directly owns 24,118 shares in the company, valued at $3,497,110. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 13,953 shares of company stock worth $2,013,630.

Agilent Technologies Stock Performance

Shares of A stock opened at $143.82 on Friday. The company’s fifty day moving average price is $140.51 and its 200-day moving average price is $138.94. The stock has a market cap of $41.32 billion, a PE ratio of 29.84, a price-to-earnings-growth ratio of 6.96 and a beta of 1.05. The company has a current ratio of 1.78, a quick ratio of 1.37 and a debt-to-equity ratio of 0.36. Agilent Technologies, Inc. has a 12 month low of $96.80 and a 12 month high of $155.35.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, August 21st. The medical research company reported $1.32 EPS for the quarter, topping the consensus estimate of $1.26 by $0.06. Agilent Technologies had a net margin of 21.75% and a return on equity of 25.26%. The business had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same quarter in the previous year, the firm posted $1.43 earnings per share. Agilent Technologies’s quarterly revenue was down 5.6% on a year-over-year basis. On average, equities analysts expect that Agilent Technologies, Inc. will post 5.24 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 23rd. Investors of record on Tuesday, October 1st will be given a dividend of $0.236 per share. This represents a $0.94 dividend on an annualized basis and a yield of 0.66%. The ex-dividend date is Tuesday, October 1st. Agilent Technologies’s dividend payout ratio (DPR) is presently 19.50%.

Analyst Ratings Changes

Several research analysts recently commented on the stock. Barclays lifted their target price on shares of Agilent Technologies from $125.00 to $135.00 and gave the stock an “underweight” rating in a research note on Friday, August 23rd. Stifel Nicolaus reaffirmed a “buy” rating and set a $151.00 price objective on shares of Agilent Technologies in a research note on Monday, August 26th. Evercore ISI raised their target price on Agilent Technologies from $135.00 to $145.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 1st. UBS Group upped their price target on Agilent Technologies from $141.00 to $150.00 and gave the company a “neutral” rating in a research report on Thursday, August 22nd. Finally, Citigroup lifted their price objective on Agilent Technologies from $150.00 to $165.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat.com, Agilent Technologies has a consensus rating of “Moderate Buy” and an average price target of $143.64.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.